Want to take quizzes and track your credits?
A global partnership plans to make 120 million coronavirus disease 2019 (COVID-19) rapid antigen tests available in low- and middle-income countries, according to an announcement from the World Health Organization’s (WHO) Access to COVID-19 Tools Accelerator.
The easy-to-administer tests can provide results in 15 to 30 minutes and can be used outside of health care settings. Through an agreement with the Bill & Melinda Gates Foundation, Abbott and SD Biosensor will make the tests available at a cost of no more than $5 each. The WHO’s Global Fund has provided $50 million from its COVID-19 Response Mechanism to help countries begin purchasing the tests. The Africa Centres for Disease Control and Prevention and Unitaid, a nongovernmental organization, began a rollout of the tests in up to 20 African countries in October 2020. The WHO and the Foundation for Innovative New Diagnostics are supporting research to determine best practices for using the tests in low- and middle-income countries.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
You currently have no searches saved.